The efficacy of antibiotic‐eluting material in a two‐stage model of periprosthetic joint infection
- 30 August 2023
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 42 (2) , 460-473
Abstract
Periprosthetic joint infections occur in about 2% of patients who undergo primary total joint arthroplasty, a procedure performed over 1 million times in the United States. The gold standard of treatment is a two‐stage revision. This study aimed to establish a two‐stage procedure in a preclinical small animal model (rat) to test and compare the efficacy of an antibiotic‐eluting material in managing infection. Joint replacement was simulated by transchondylarly implanting a polyethylene (PE) plug into the distal femur and a titanium screw in the proximal tibia. Methicillin‐sensitive Staphylococcus aureus (MSSA) 108 CFU/mL was injected into the tibial canal and the joint space before wound closure. The control groups were killed on postoperative day (POD) 18 (n = 12) and on POD 42 (n = 4) to assess both early and later‐stage outcomes in the control group. The test group underwent revision surgery on POD 18 for treatment using gentamicin‐eluting polyethylene (GPE, n = 4) and was observed until POD 42 to evaluate the efficacy of treatment. Our results showed that the bone loss for the treatment group receiving GPE was significantly less than that of the control (p < 0.05), which was supported by the histology images and an AI‐tool assisted infection rate evaluation. Gait metrics duty factor imbalance and hindlimb temporal symmetry were significantly different between the treatment and control groups on Day 42. This animal model was feasible for evaluating treatments for peri‐prosthetic joint infections (PJI) with a revision surgery and specifically that revision surgery and local antibiotic treatment largely hindered the peri‐prosthetic bone loss. Statement of clinical significance: This revision model of peri‐prosthetic infection has the potential of comparatively evaluating prophylaxis and treatment strategies and devices. Antibiotic‐eluting UHMWPE is devised as at tool in treating PJI while providing weight bearing and joint space preservation.Keywords
This publication has 35 references indexed in Scilit:
- A Mouse Model of Post-Arthroplasty Staphylococcus aureus Joint Infection to Evaluate In Vivo the Efficacy of Antimicrobial Implant CoatingsPLOS ONE, 2010
- Two-stage total infected knee arthroplasty treatment with articulating cement spacerArchives of orthopaedic and trauma surgery, 2010
- Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases PharmacistsClinical Infectious Diseases, 2009
- Interleukin-6, procalcitonin and TNF-αThe Journal of Bone and Joint Surgery. British volume, 2007
- Comparison of 18F-FDG and 68Ga PET imaging in the assessment of experimental osteomyelitis due to Staphylococcus aureusEuropean Journal of Nuclear Medicine and Molecular Imaging, 2005
- Establishment of rat model of acute staphylococcal osteomyelitis: relationship between inoculation dose and development of osteomyelitisArchives of orthopaedic and trauma surgery, 2005
- Prosthetic Joint Infections: Bane of Orthopedists, Challenge for Infectious Disease SpecialistsClinical Infectious Diseases, 2003
- Antibiotic prophylaxis in total hip arthroplastyEffects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty RegisterActa Orthopaedica, 2003
- Infection in Total Knee ReplacementClinical Orthopaedics and Related Research, 2001
- Modified Stain for Identification ofStaphylococcus aureusin OsteomyelitisJournal of Histotechnology, 1992